Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;25(1):55-72.
doi: 10.1002/jhbp.516. Epub 2017 Dec 20.

Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis

Affiliations
Free article
Review

Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis

Kohji Okamoto et al. J Hepatobiliary Pancreat Sci. 2018 Jan.
Free article

Erratum in

  • Corrigendum.
    [No authors listed] [No authors listed] J Hepatobiliary Pancreat Sci. 2019 Nov;26(11):534. doi: 10.1002/jhbp.686. J Hepatobiliary Pancreat Sci. 2019. PMID: 31658506 No abstract available.

Abstract

We propose a new flowchart for the treatment of acute cholecystitis (AC) in the Tokyo Guidelines 2018 (TG18). Grade III AC was not indicated for straightforward laparoscopic cholecystectomy (Lap-C). Following analysis of subsequent clinical investigations and drawing on Big Data in particular, TG18 proposes that some Grade III AC can be treated by Lap-C when performed at advanced centers with specialized surgeons experienced in this procedure and for patients that satisfy certain strict criteria. For Grade I, TG18 recommends early Lap-C if the patients meet the criteria of Charlson comorbidity index (CCI) ≤5 and American Society of Anesthesiologists physical status classification (ASA-PS) ≤2. For Grade II AC, if patients meet the criteria of CCI ≤5 and ASA-PS ≤2, TG18 recommends early Lap-C performed by experienced surgeons; and if not, after medical treatment and/or gallbladder drainage, Lap-C would be indicated. TG18 proposes that Lap-C is indicated in Grade III patients with strict criteria. These are that the patients have favorable organ system failure, and negative predictive factors, who meet the criteria of CCI ≤3 and ASA-PS ≤2 and who are being treated at an advanced center (where experienced surgeons practice). If the patient is not considered suitable for early surgery, TG18 recommends early/urgent biliary drainage followed by delayed Lap-C once the patient's overall condition has improved. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included.

Keywords: Acute cholecystitis; Biliary drainage; Flowchart; Laparoscopic cholecystectomy; Risk factor.

PubMed Disclaimer

Comment in

Similar articles

  • Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos).
    Wakabayashi G, Iwashita Y, Hibi T, Takada T, Strasberg SM, Asbun HJ, Endo I, Umezawa A, Asai K, Suzuki K, Mori Y, Okamoto K, Pitt HA, Han HS, Hwang TL, Yoon YS, Yoon DS, Choi IS, Huang WS, Giménez ME, Garden OJ, Gouma DJ, Belli G, Dervenis C, Jagannath P, Chan ACW, Lau WY, Liu KH, Su CH, Misawa T, Nakamura M, Horiguchi A, Tagaya N, Fujioka S, Higuchi R, Shikata S, Noguchi Y, Ukai T, Yokoe M, Cherqui D, Honda G, Sugioka A, de Santibañes E, Supe AN, Tokumura H, Kimura T, Yoshida M, Mayumi T, Kitano S, Inomata M, Hirata K, Sumiyama Y, Inui K, Yamamoto M. Wakabayashi G, et al. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):73-86. doi: 10.1002/jhbp.517. Epub 2018 Jan 10. J Hepatobiliary Pancreat Sci. 2018. PMID: 29095575 Review.
  • Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis.
    Miura F, Okamoto K, Takada T, Strasberg SM, Asbun HJ, Pitt HA, Gomi H, Solomkin JS, Schlossberg D, Han HS, Kim MH, Hwang TL, Chen MF, Huang WS, Kiriyama S, Itoi T, Garden OJ, Liau KH, Horiguchi A, Liu KH, Su CH, Gouma DJ, Belli G, Dervenis C, Jagannath P, Chan ACW, Lau WY, Endo I, Suzuki K, Yoon YS, de Santibañes E, Giménez ME, Jonas E, Singh H, Honda G, Asai K, Mori Y, Wada K, Higuchi R, Watanabe M, Rikiyama T, Sata N, Kano N, Umezawa A, Mukai S, Tokumura H, Hata J, Kozaka K, Iwashita Y, Hibi T, Yokoe M, Kimura T, Kitano S, Inomata M, Hirata K, Sumiyama Y, Inui K, Yamamoto M. Miura F, et al. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):31-40. doi: 10.1002/jhbp.509. Epub 2018 Jan 8. J Hepatobiliary Pancreat Sci. 2018. PMID: 28941329 Review.
  • Validation of the Tokyo guideline 2018 treatment proposal for acute cholecystitis from a single-center retrospective analysis.
    Bekki T, Abe T, Amano H, Hanada K, Kobayashi T, Noriyuki T, Ohdan H, Nakahara M. Bekki T, et al. Asian J Endosc Surg. 2021 Jan;14(1):14-20. doi: 10.1111/ases.12801. Epub 2020 Apr 13. Asian J Endosc Surg. 2021. PMID: 32285589
  • Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis.
    Mayumi T, Okamoto K, Takada T, Strasberg SM, Solomkin JS, Schlossberg D, Pitt HA, Yoshida M, Gomi H, Miura F, Garden OJ, Kiriyama S, Yokoe M, Endo I, Asbun HJ, Iwashita Y, Hibi T, Umezawa A, Suzuki K, Itoi T, Hata J, Han HS, Hwang TL, Dervenis C, Asai K, Mori Y, Huang WS, Belli G, Mukai S, Jagannath P, Cherqui D, Kozaka K, Baron TH, de Santibañes E, Higuchi R, Wada K, Gouma DJ, Deziel DJ, Liau KH, Wakabayashi G, Padbury R, Jonas E, Supe AN, Singh H, Gabata T, Chan ACW, Lau WY, Fan ST, Chen MF, Ker CG, Yoon YS, Choi IS, Kim MH, Yoon DS, Kitano S, Inomata M, Hirata K, Inui K, Sumiyama Y, Yamamoto M. Mayumi T, et al. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):96-100. doi: 10.1002/jhbp.519. Epub 2017 Dec 16. J Hepatobiliary Pancreat Sci. 2018. PMID: 29090868 Review.
  • Evaluating the advantages of treating acute cholecystitis by following the Tokyo Guidelines 2018 (TG18): a study emphasizing clinical outcomes and medical expenditures.
    Lin YN, Wu YT, Fu CY, Liao CH, Cheng CT, Wang SY, Lin BC, Hsu YP, Kang SC, Liu EH, Kuo IM, Ou Yang CH, Yang SJ, Huang JF, Hsu CP, Hsieh FJ, Liao CA, Kuo LW, Tee YS, Hsieh CH. Lin YN, et al. Surg Endosc. 2021 Dec;35(12):6623-6632. doi: 10.1007/s00464-020-08162-7. Epub 2020 Nov 30. Surg Endosc. 2021. PMID: 33258028

Cited by